These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 8306345
1. Bombesin receptors in a human duodenal tumor cell line: binding properties and function. Williams BY, Schonbrunn A. Cancer Res; 1994 Feb 01; 54(3):818-24. PubMed ID: 8306345 [Abstract] [Full Text] [Related]
2. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Frucht H, Gazdar AF, Park JA, Oie H, Jensen RT. Cancer Res; 1992 Mar 01; 52(5):1114-22. PubMed ID: 1310640 [Abstract] [Full Text] [Related]
3. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro. Narayan S, Guo YS, Townsend CM, Singh P. Cancer Res; 1990 Nov 01; 50(21):6772-8. PubMed ID: 2208141 [Abstract] [Full Text] [Related]
4. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors. Benya RV, Wada E, Battey JF, Fathi Z, Wang LH, Mantey SA, Coy DH, Jensen RT. Mol Pharmacol; 1992 Dec 01; 42(6):1058-68. PubMed ID: 1336112 [Abstract] [Full Text] [Related]
5. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects. Narayan S, Spindel ER, Rubin NH, Singh P. Cell Growth Differ; 1992 Feb 01; 3(2):111-8. PubMed ID: 1323998 [Abstract] [Full Text] [Related]
6. Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide. Moody TW, Mahmoud S, Staley J, Naldini L, Cirillo D, South V, Felder S, Kris R. J Mol Neurosci; 1989 Feb 01; 1(4):235-42. PubMed ID: 2561955 [Abstract] [Full Text] [Related]
7. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. Benya RV, Akeson M, Mrozinski J, Jensen RT, Battey JF. Mol Pharmacol; 1994 Sep 01; 46(3):495-501. PubMed ID: 7935330 [Abstract] [Full Text] [Related]
8. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Qin Y, Ertl T, Cai RZ, Halmos G, Schally AV. Cancer Res; 1994 Feb 15; 54(4):1035-41. PubMed ID: 8313359 [Abstract] [Full Text] [Related]
9. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes. Lin JT, Coy DH, Mantey SA, Jensen RT. J Pharmacol Exp Ther; 1995 Oct 15; 275(1):285-95. PubMed ID: 7562561 [Abstract] [Full Text] [Related]
10. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. Mantey S, Frucht H, Coy DH, Jensen RT. Mol Pharmacol; 1993 May 15; 43(5):762-74. PubMed ID: 7684815 [Abstract] [Full Text] [Related]
12. Agonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites. Williams BY, Wang Y, Schonbrunn A. Mol Pharmacol; 1996 Oct 15; 50(4):716-27. PubMed ID: 8863815 [Abstract] [Full Text] [Related]
13. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. Halmos G, Wittliff JL, Schally AV. Cancer Res; 1995 Jan 15; 55(2):280-7. PubMed ID: 7812958 [Abstract] [Full Text] [Related]
14. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K. Cancer Res; 1994 Nov 15; 54(22):5895-901. PubMed ID: 7954420 [Abstract] [Full Text] [Related]
15. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP. Benya RV, Fathi Z, Kusui T, Pradhan T, Battey JF, Jensen RT. Mol Pharmacol; 1994 Aug 15; 46(2):235-45. PubMed ID: 8078487 [Abstract] [Full Text] [Related]
16. High affinity binding sites for gastrin releasing peptide on human gastric cancer and Ménétrier's mucosa. Preston SR, Woodhouse LF, Jones-Blackett S, Wyatt JI, Primrose JN. Cancer Res; 1993 Nov 01; 53(21):5090-2. PubMed ID: 8221641 [Abstract] [Full Text] [Related]
17. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression. Thomas F, Arvelo F, Antoine E, Jacrot M, Poupon MF. Cancer Res; 1992 Sep 15; 52(18):4872-7. PubMed ID: 1325285 [Abstract] [Full Text] [Related]
18. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi. Radulovic S, Cai RZ, Serfozo P, Groot K, Redding TW, Pinski J, Schally AV. Int J Pept Protein Res; 1991 Dec 15; 38(6):593-600. PubMed ID: 1726427 [Abstract] [Full Text] [Related]
19. Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line. Saurin JC, Némoz-Gaillard E, Sordat B, Cuber JC, Coy DH, Abello J, Chayvialle JA. Cancer Res; 1999 Feb 15; 59(4):962-7. PubMed ID: 10029091 [Abstract] [Full Text] [Related]
20. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium. Amiot F, Leiber D, Marc S, Harbon S. Am J Physiol; 1993 Dec 15; 265(6 Pt 1):C1579-87. PubMed ID: 8279518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]